Patents by Inventor Shengmei XU

Shengmei XU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10632100
    Abstract: Disclosed is application of obacunone in the manufacture of a medicament for prevention or treatment of lung injury and pulmonary fibrosis. The medicament consists of obacunone and pharmaceutically acceptable auxiliaries and additives, wherein obacunone is 3% to 25% by mass in the medicament. The obacunone in the medicament can inhibit bleomycin-induced lung injury and pulmonary fibrosis in mice, and regulate the expression of the inflammation-associated cytokines in the bleomycin-induced injured lung tissue in mice.
    Type: Grant
    Filed: February 28, 2017
    Date of Patent: April 28, 2020
    Assignee: GUANGDONG PROVINCIAL HOSPITAL OF TRADITIONAL CHINESE MEDICINE
    Inventors: Yang Xu, Shengmei Xu, Weimin Chen
  • Publication number: 20190046502
    Abstract: Disclosed is application of obacunone in the manufacture of a medicament for prevention or treatment of lung injury and pulmonary fibrosis. The medicament consists of obacunone and pharmaceutically acceptable auxiliaries and additives, wherein obacunone is 3% to 25% by mass in the medicament. The obacunone in the medicament can inhibit bleomycin-induced lung injury and pulmonary fibrosis in mice, and regulate the expression of the inflammation-associated cytokines in the bleomycin-induced injured lung tissue in mice.
    Type: Application
    Filed: February 28, 2017
    Publication date: February 14, 2019
    Applicant: GUANGDONG PROVINCIAL HOSPITAL OF TRADITIONAL CHINESE MEDICINE
    Inventors: Yang XU, Shengmei XU, Weimin CHEN